Can Kegels help if you can’t get it up?
Kegels may help erectile function for some men as part of an assessed pelvic-floor programme, but the evidence is limited and does not support calling PFMT a cure or universal first-line treatment for erectile dysfunction (ED). Studies have used different exercise protocols, therapist contact, biofeedback, lifestyle advice, and comparison treatments. The current EAU guideline describes PFMT combined with biofeedback as promising while asking for stronger trials.
ED can reflect vascular, cardiovascular, neurological, hormonal, medicine-related, structural, post-surgical, psychological, relational, or mixed contributors. Pelvic-floor training cannot identify or treat all of these. New, persistent, or bothersome ED should be medically assessed before an app routine becomes the main plan.
What erectile dysfunction means
ED describes a recurring difficulty obtaining or maintaining an erection sufficient for desired sexual activity. One erection that changes with fatigue, stress, alcohol, unfamiliar circumstances, or relationship context does not by itself establish a disorder. Persistence, pattern, distress, and medical context matter.
Erections are neurovascular events. Nerves coordinate arousal signals, arteries deliver blood, erectile tissue fills, and venous outflow is restricted. Hormones, medicines, pain, sleep, mood, relationship factors, and pelvic or prostate treatment can influence the process. Pelvic-floor muscles contribute to parts of sexual function, but they are one element in a larger system.
The EAU erectile-dysfunction guideline explicitly calls ED a symptom rather than a disease and emphasizes evaluation for underlying conditions and cardiovascular risk. That makes an exercise-only explanation unsafe.
Why the pelvic floor might matter
Muscles around the base of the penis and perineum can contribute to pressure and the mechanical support of erection and ejaculation. Pelvic-floor coordination may also interact with continence, breathing, sexual activity, and recovery after pelvic treatment. This anatomical rationale makes PFMT worth studying.
Rationale is not the same as proof that weakness caused an individual’s ED. A person may have normal pelvic-floor strength with vascular ED, impaired nerve signalling after surgery, low testosterone, medication effects, pain-related guarding, or another contributor. Conversely, a pelvic-floor programme may be relevant even when it is not the only treatment.
What the research says
The 2019 systematic review
A 2019 systematic review by Myers and Smith included ten trials of adult men with ED or premature ejaculation. The studies reported positive comparative signals, but protocols differed substantially in therapist contact, concurrent interventions, duration, frequency, intensity, and outcomes. Study quality ranged from low to moderate, and heterogeneity prevented pooled analysis. The review could not identify an optimal protocol.
This means the evidence supports further investigation and a possible adjunctive role. It does not show that a generic unsupervised Kegel timer reproduces the studied interventions or that PFMT works equally across ED causes.
Current guideline interpretation
The 2026 EAU guideline describes a systematic review of PFMT combined with biofeedback as promising but states that adequately powered, rigorously designed randomized trials are needed. The guideline’s established treatment pathway focuses on assessment, risk-factor modification, patient preferences, and proven medical options. It does not elevate Kegels to a universal first-line ED treatment.
Why bundled programmes complicate the answer
When a study combines pelvic-floor instruction with biofeedback, therapist review, lifestyle changes, or another intervention, improvement cannot automatically be attributed to contractions alone. Supervision may correct technique, tailor the load, support adherence, and identify people whose symptoms need another pathway. An app omits much of that bundle.
No established dose or response deadline
The research does not define one hold time, repetition count, weekly frequency, or guaranteed time to benefit. Copying a protocol from a small trial can be inappropriate for someone with a different cause, pain pattern, surgical history, or baseline muscle function.
Who might discuss PFMT as an adjunct?
PFMT may be worth discussing when a clinician or pelvic-health physiotherapist identifies a relevant pelvic-floor contribution, when the person can contract and fully release without pain, or when pelvic rehabilitation is already part of care after an appropriate procedure. It may sit alongside cardiovascular risk management, medication review, counselling, medical treatment, or other rehabilitation.
The decision should not be based on age, masculinity, erection firmness, or the ability to squeeze strongly. The ICS assessment framework separates strength, endurance, coordination, and relaxation. ED does not reveal which quality, if any, needs training.
When strengthening may be mismatched
Pause self-guided Kegels and seek assessment if you have pelvic, penile, testicular, rectal, or abdominal pain; painful erection or ejaculation; urinary hesitancy, weak stream, or incomplete emptying; constipation with blockage; or a pelvic floor that feels more clenched after practice. These symptoms may involve overactivity, coordination, an organ or nerve condition, or another cause.
The EAU chronic-pelvic-pain guideline places treatment of pelvic-floor overactivity inside specialist pain care. Adding stronger contractions is not an appropriate way to test whether pain-related ED is muscular.
After prostate, bladder, colorectal, or other pelvic surgery, timing and sexual rehabilitation should follow the treatment team. A general Kegel programme cannot account for nerve injury, vascular change, tissue healing, catheter status, or cancer-treatment effects.
Medical assessment still matters
ED may be an early sign of vascular or metabolic disease. It can coexist with high blood pressure, diabetes, lipid disorders, smoking, obesity, endocrine conditions, neurological disease, depression, anxiety, sleep problems, and medication effects. Assessment also considers sexual desire, ejaculation, pain, curvature, operations, and relationship context.
NIDDK’s diagnosis guidance describes medical, sexual, and mental-health history, physical examination, and selected laboratory or imaging tests. Not every person needs every test, but a workout self-test cannot perform this role.
Read when erectile dysfunction needs medical assessment for a practical decision framework.
If PFMT is included in your plan
An individualized programme should first confirm a correct inward contraction and a complete, comfortable release. The goal may involve awareness, control, endurance, timing, or coordination rather than maximal force. Progress should reflect technique, symptoms, recovery, and the wider treatment plan.
Do not invent a high-volume programme to accelerate results. Do not repeatedly contract during sexual activity as an unsupervised performance test. Stop if practice causes pain, pressure, urinary or bowel difficulty, or lingering tension, and ask the relevant clinician to review the plan.
Track meaningful outcomes agreed with the clinician, not only workout completion. Changes in erections can vary with context, medicines, sleep, health, and partner situation, so one good or difficult occasion does not prove an exercise effect.
Interpreting change without over-crediting the exercise
If erectile function improves while several things change—such as cardiovascular treatment, sleep, medication, anxiety, relationship context, alcohol use, or pelvic-floor practice—it is usually impossible to assign the result to Kegels alone. Likewise, a lack of improvement does not prove that the person performed the exercise badly or failed rehabilitation.
Use a planned clinical review to decide whether the original explanation still fits, whether the programme is worth continuing, and whether another treatment should be added or prioritized. Do not delay established ED care for months while waiting for an app streak to produce a result.
PelvicEx cannot diagnose the cause of ED. It cannot assess blood flow, cardiovascular risk, nerves, hormones, medicines, penile structure, psychological or relational factors, pelvic-floor tone, or surgical recovery. It also cannot reproduce therapist biofeedback used in parts of the evidence base.
How to interpret a positive group result
A trial can show that a PFMT group improved more than a comparison group without proving that pelvic-floor weakness caused every participant’s ED. The intervention may include instruction, biofeedback, therapist review, lifestyle advice, or another treatment in addition to repeated contractions. The comparison may receive no equivalent contact. Those design choices influence what can be attributed to the muscle exercise itself.
Outcome choice also matters. An erectile-function questionnaire combines several aspects of sexual experience and may not isolate erection firmness, duration, confidence, distress, or satisfaction. A statistically significant average change may be meaningful, modest, or uncertain for an individual depending on baseline severity and the scale’s interpretation. The published group effect cannot set a personal response deadline.
Applicability requires matching the population. Evidence from selected adult men without major neurological injury or urological surgery should not be transferred automatically to post-prostatectomy ED, pelvic pain, Peyronie’s disease, medication-related ED, or a person with major cardiovascular risk. The anatomical rationale for pelvic-floor involvement remains plausible across some settings, but clinical directness is lower when the studied and real populations differ.
For PelvicEx, a timed self-guided session is still not equivalent to a supervised PFMT-and-biofeedback package. The product has no body sensor or live technique feedback and cannot measure erections. Its timing cues and local completion records may support consistency, but they cannot reproduce medical assessment, palpation, biofeedback interpretation, or treatment of vascular and hormonal contributors.
What stronger evidence would need to show
Confidence would increase with adequately powered randomized trials that define ED causes and severity, verify pelvic-floor technique, describe contraction and relaxation content, separate PFMT from biofeedback and other co-interventions, and use patient-important outcomes with sufficient follow-up. Adverse effects such as pelvic pain, urinary symptoms, or increased resting tension should be collected deliberately rather than mentioned only when spontaneously reported.
Trials should report assigned and completed dose, therapist contact, adherence quality, and reasons for withdrawal. They should also state whether cardiovascular, endocrine, medication, psychological, and relationship contributors were assessed and treated. Without those details, a result can be encouraging while the active component and best candidate remain uncertain.
Replication across independent teams and relevant populations would matter more than one unusually favorable small study. Comparisons should include credible usual care or established ED pathways, not imply that PFMT must replace them. Longer follow-up is needed to know whether any change persists after supervised contact ends and whether maintenance practice is necessary.
Until that evidence exists, the accurate conclusion is a possible adjunctive benefit for selected men, not a universal first-line recommendation or cure claim. A person considering PFMT can still make an informed trial with a defined goal, correct technique, stop rules, and review point while receiving complete ED care.
Bottom line
PFMT has a plausible mechanism and a positive but uncertain research signal for selected men with ED. The evidence is not strong enough to promise cure, specify one protocol, or replace medical evaluation and established treatment. The responsible sequence is assessment first, then adjunctive pelvic-floor training when the findings and goals support it.
Sources
- Greenhalgh T, Dijkstra P. How to Read a Paper: The Basics of Evidence-Based Healthcare. 7th edition. Wiley; 2025. Official publisher record.
- European Association of Urology. Sexual and Reproductive Health Guideline: Management of Erectile Dysfunction. 2026 edition. Current guideline.
- Myers C, Smith M. “Pelvic floor muscle training improves erectile dysfunction and premature ejaculation: a systematic review.” Physiotherapy. 2019;105(2):235–243. PubMed record.
- National Institute of Diabetes and Digestive and Kidney Diseases. “Diagnosis of Erectile Dysfunction.” Last reviewed October 2024. NIDDK guidance.
- Frawley H et al. “An International Continence Society report on the terminology for pelvic floor muscle assessment.” Neurourology and Urodynamics. 2021;40:1217–1260. Official ICS report.
- Bø K, Berghmans B, Mørkved S, Van Kampen M, editors. Evidence-Based Physical Therapy for the Pelvic Floor. 3rd edition. Elsevier; 2023. Chapter 11. Official publisher record.